Summary by Futu AI
In a recent transaction, Theodore R. II Samuels, a reporting person for Bristol-Myers Squibb (BMY), engaged in a stock market action on June 30, 2024. Specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Samuels' position and the potential implications for Bristol-Myers Squibb's stock.